Florida / New York

Ph: 561.316.3330

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

The medical device space is growing rapidly as new startups and investments from major players enter the market. Some of the most notable investors in medical devices include venture capital firms such as Kleiner Perkins Caufield & Byers, Sequoia Capital, and Accel Partners, as well as large companies such as Johnson & Johnson and Medtronic.

This influx of investment is driving innovation in the medical device space, with new devices and treatments being developed all the time. This growth is also creating opportunities for entrepreneurs, who can now launch their own medical device startups and access funding from major players.

Medtronic Diabetes
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

Medtronic Diabetes REPORTS World’s 1st Approval for MiniMed™ 780G System with Simplera Sync™ Disposable, All-in-one Sensor

Que Dallara, EVP and President, Medtronic Diabetes comments….

“We’re incredibly proud that the MiniMed™ 780G system continues to be the most widely used automated insulin delivery system in Europe since we launched it in 2020. Real-world data on over 100,000 users on the system across many geographies and cultures shows that when using recommended settings the system is delivering an average Time in Range of nearly 80%, raising the bar on what ‘good’ looks like.”

Read More »
HR Pharmaceuticals
MEDICAL DEVICES, TECHNOLOGIES, EQUIPMENT, SUPPLIES

HR Pharmaceuticals Receives Exclusive Commercialization Rights to Poiesis Medical’s Dual Balloon Catheter Technology in No America

The Dual Balloon Catheter has demonstrated significant benefits compared to traditional Foley catheters, leading to better patient outcomes. Specifically, we see a great opportunity for patients requiring indwelling catheterization greater than five days. This product will become an important part of our broader urology strategy over the next 12 months,” states Colby Wiesman, President of HR Pharmaceuticals, Inc. 

Read More »

Inspira Technologies Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients

Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership’s significance: “By Integrating our technology to oxygenate blood directly with Ennocure’s infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology.”

Read More »